Clinical efficacy of a single two Gram dose of azithromycin extended release for male patients with urethritis

Antibiotics

Volumn 3, Issue 2, 2014, Pages 109-120

  Takahashi, Satoshi ^a   Kiyota, Hiroshi ^b   Ito, Shin ^c   Iwasawa, Akihiko ^a   Hiyama, Yoshiki ^a   Uehara, Teruhisa ^a   Ichihara, Koji ^a   Hashimoto, Jiro ^a   Masumori, Naoya ^a   Sunaoshi, Kenichi ^d   Takeda, Koichi ^d   Suzuki, Nobukazu ^d   Hosobe, Takahide ^e   Goto, Hirokazu ^f   Suzuki, Hidenori ^f   Onodera, Shoichi ^f  

^a SAPPORO MEDICAL UNIVERSITY SCHOOL OF MEDICINE   (Japan)

^b Jikei University School of Medicine   (Japan)

^c IClinic   (Japan)

^d Teine Urologic Clinic   (Japan)

^e Hosobe Clinic   (Japan)

^f Fuji City General Hospital   (Japan)

Author keywords

Azithromycin; Chlamydia trachomatis; Extended release; Mycoplasma genitalium; Neisseria gonorrhoeae; Ureaplasma urealyticum; Urethritis

Indexed keywords

AZITHROMYCIN; CEFIXIME; CEFODIZIME; CEFTRIAXONE; CIPROFLOXACIN; LEVOFLOXACIN; PENICILLIN G; SPECTINOMYCIN;

ABDOMINAL PAIN; ADULT; AGED; ANTIBIOTIC SENSITIVITY; ARTICLE; CHLAMYDIA TRACHOMATIS; CLINICAL TRIAL; CONTROLLED STUDY; CULTURE MEDIUM; DIARRHEA; DISEASE ERADICATION; DRUG EFFICACY; DRUG RELEASE; GONOCOCCAL URETHRITIS; HUMAN; MAJOR CLINICAL STUDY; MALE; MIDDLE AGED; MINIMUM INHIBITORY CONCENTRATION; MYCOPLASMA GENITALIUM; NAUSEA; NEISSERIA GONORRHOEAE; NONHUMAN; OPEN STUDY; POLYMERASE CHAIN REACTION; PRIORITY JOURNAL; PROSPECTIVE STUDY; SINGLE DRUG DOSE; TREATMENT OUTCOME; UREAPLASMA UREALYTICUM; URETHRITIS; YOUNG ADULT;

EID: 84939546431     PISSN: None     EISSN: 20796382     Source Type: Journal    
DOI: 10.3390/antibiotics3020109     Document Type: Article

References (30)

1. Wetmore, C.M.; Manhart, L.E.; Lowens, M.S.; Golden, M.R.; Whittington, W.L.; Xet-Mull, A.M.; Astete, S.G.; McFarland, N.L.; McDougal, S.J.; Totten, P.A. Demographic, behavioral, and clinical characteristics of men with nongonococcal urethritis differ by etiology: A case-comparison study. Sex. Transm. Dis. 2011, 38, 180-186.
2. Centers for Disease Control and Prevention. Update to CDC's sexually transmitted diseases treatment guidelines, 2010: Oral cephalosporins no longer a recommended treatment for gonococcal infections. Morb. Mortal. Wkly. Rep. 2012, 10, 590-594.
3. Workowski, K.A.; Berman, S.; Centers for Disease Control and Prevention. Sexually transmitted diseases treatment guidelines, 2010. Morb. Mortal. Wkly. Rep. 2010, 59, 1-110.
4. Chisholm, S.A.; Neal, T.J.; Alawattegama, A.B.; Birley, H.D.; Howe, R.A.; Ison, C.A. Emergence of high-level azithromycin resistance in Neisseria gonorrhoeae in England and Wales. J. Antimicrob. Chemother. 2009, 64, 353-358.
5. Galarza, P.G.; Alcala, B.; Salcedo, C.; Canigia, L.F.; Buscemi, L.; Pagano, I.; Oviedo, C.; Vázquez, J.A. Emergence of high level azithromycin-resistant Neisseria gonorrhoeae strain isolated in Argentina. Sex. Transm. Dis. 2009, 36, 787-788.
6. Starnino, S.; Stefanelli, P. Neisseria gonorrhoeae Italian Study G. Azithromycin-resistant Neisseria gonorrhoeae strains recently isolated in Italy. J. Antimicrob. Chemother. 2009, 63, 1200-1204.
7. Bradshaw, C.S.; Jensen, J.S.; Tabrizi, S.N.; Read, T.R.; Garland, S.M.; Hopkins, C.A.; Moss, L.M.; Fairley, C.K. Azithromycin failure in Mycoplasma genitalium urethritis. Emerg. Infect. Dis. 2006, 12, 1149-1152.
8. Jensen, J.S.; Bradshaw, C.S.; Tabrizi, S.N.; Fairley, C.K.; Hamasuna, R. Azithromycin treatment failure in Mycoplasma genitalium-positive patients with nongonococcal urethritis is associated with induced macrolide resistance. Clin. Infect. Dis. 2008, 47, 1546-1553.
9. Manhart, L.E.; Gillespie, C.W.; Lowens, M.S.; Khosropour, C.M.; Colombara, D.V.; Golden, M.R.; Hakhu, N.R.; Thomas, K.K.; Hughes, J.P.; Jensen, N.L.;. Standard treatment regimens for nongonococcal urethritis have similar but declining cure rates: A randomized controlled trial. Clin. Infect. Dis. 2013, 56, 934-942.
10. Jain, R.; Danziger, L.H. The macrolide antibiotics: A pharmacokinetic and pharmacodynamic overview. Curr. Pharm. Des. 2004, 10, 3045-3053.
11. Handsfield, H.H.; Dalu, Z.A.; Martin, D.H.; Douglas, J.M., Jr.; McCarty, J.M.; Schlossberg, D.; Azithromycin Gonorrhea Study Group. Multicenter trial of single-dose azithromycin vs. ceftriaxone in the treatment of uncomplicated gonorrhea. Sex Transm. Dis. 1994, 21, 107-111.
12. Chandra, R.; Liu, P.; Breen, J.D.; Fisher, J.; Xie, C.; LaBadie, R.; Benner, R.J.; Benincosa, L.J.; Sharma, A. Clinical pharmacokinetics and gastrointestinal tolerability of a novel extended-release microsphere formulation of azithromycin. Clin. Pharm. 2007, 46, 247-259.
13. Yasuda, M.; Takahashi, S.; Kiyota, H.; Ishikawa, K.; Takahashi, A.; Yamamoto, S.; Arakawa, S.; Monden, K.; Muratani, T.; Hamasuna, R.;. Japanese guideline for clinical research of antimicrobial agents on urogenital infections: The first edition. J. Infect. Chemother. 2011, 17, 579-594.
14. Takahashi, S.; Takeyama, K.; Kunishima, Y.; Takeda, K.; Suzuki, N.; Nishimura, M.; Furuya, R.; Tsukamoto, T. Analysis of clinical manifestations of male patients with urethritis. J. Infect. Chemother. 2006, 12, 283-286.
15. Saika, T.; Nishiyama, T.; Kanayama, A.; Kobayashi, I.; Nakayama, H.; Tanaka, M.; Naito, S. Comparison of Neisseria gonorrhoeae isolates from the genital tract and pharynx of two gonorrhea patients. J. Infect. Chemother. 2001, 7, 175-179.
16. Yoshida, T.; Maeda, S.; Deguchi, T.; Ishiko, H. Phylogeny-based rapid identification of mycoplasmas and ureaplasmas from urethritis patients. J. Clin. Microbiol. 2002, 40, 105-110.
17. The European Committee on Antimicrobial Susceptibility Testing-EUCAST. Available online: http://www.escmid.org/reseach_projects/eucast/ (accessed on 19 March 2014).
18. Institutional Review Board of Sapporo Medical University Hospital. Available online: http://web.sapmed.ac.jp/byoin/chiken/irb.html/ (accessed on 19 March 2014).
19. University Hospital Medical Information Network Clinical Trial Registry (UMIN-CTR). Available online: http://www.umin.ac.jp/ctr/index-j.htm/ (accessed on 19 March 2014).
20. Bolan, G.A.; Sparling, P.F.; Wasserheit, J.N. The emerging threat of untreatable gonococcal infection. N. Engl. J. Med. 2012, 366, 485-487.
21. Centers for Disease Control and Prevention. Cephalosporin susceptibility among Neisseria gonorrhoeae isolates-United States, 2000-2010. Morb. Mortal. Wkly. Rep. 2011, 60, 873-877.
22. Ohnishi, M.; Saika, T.; Hoshina, S.; Iwasaku, K.; Nakayama, S.; Watanabe, H.; Kitawaki, J. Ceftriaxone-resistant Neisseria gonorrhoeae, Japan. Emerg. Infect. Dis. 2011, 17, 148-149.
23. Takahashi, S.; Matsukawa, M.; Kurimura, Y.; Takeyama, K.; Kunishima, Y.; Iwasawa, A.; Koroku, M.; Tanda, H.; Suzuki, N.; Takagi, Y.; Clinical efficacy of azithromycin for male nongonococcal urethritis. J. Infect. Chemother. 2008, 14, 409-412.
24. Khaki, P.; Bhalla, P.; Sharma, A.; Kumar, V. Correlation between in vitro susceptibility and treatment outcome with azithromycin in gonorrhoea: A prospective study. Ind. J. Med. Microbiol. 2007, 25, 354-357.
25. Endo, K.; Onodera, S.; Kiyota, H.; Suzuki, H.; Hosobe, T.; Naruoka, T.; Sanuki, K. Drug-susceptibilities of Neisseria gonorrhoeae strains isolated from male patients with gonococcal urethritis against antimicrobial agents-Comparisons from 2006 to 2010. Jpn. J. Chemother. 2011, 59, 308-312.
26. Hamasuna, R.; Yasuda, M.; Ishikawa, K.; Uehara, S.; Takahashi, S.; Hayami, H.; Yamamoto, S.; Matsumoto, T.; Minamitani, S.; Watanabe, A.;. Nationwide surveillance of the antimicrobial susceptibility of Neisseria gonorrhoeae from male urethritis in Japan. J. Infect. Chemother. 2013, 19, 571-578.
27. Katz, A.R.; Komeya, A.Y.; Soge, O.O.; Kiaha, M.I.; Lee, M.V.; Wasserman, G.M.; Maningas, E.V.; Whelen, A.C.; Kirkcaldy, R.D.; Shapiro, S.J.; e. Neisseria gonorrhoeae with high-level resistance to azithromycin: Case report of the first isolate identified in the United States. Clin. Infect. Dis. 2012, 54, 841-843.
28. Takahashi, S.; Ichihara, K.; Hashimoto, J.; Kurimura, Y.; Iwasawa, A.; Hayashi, K.; Sunaoshi, K.; Takeda, K.; Suzuki, N.; Satoh, T.;. Clinical efficacy of levofloxacin 500 mg once daily for 7 days for patients with non-gonococcal urethritis. J. Infect. Chemother. 2011, 17, 392-396.
29. Ito, S.; Yasuda, M.; Seike, K.; Sugawara, T.; Tsuchiya, T.; Yokoi, S.; Nakano, M.; Deguchi, T. Clinical and microbiological outcomes in treatment of men with non-gonococcal urethritis with a 100-mg twice-daily dose regimen of sitafloxacin. J. Infect. Chemother. 2012, 18, 414-418.
30. Takahashi, S.; Hamasuna, R.; Yasuda, M.; Ito, S.; Ito, K.; Kawai, S.; Yamaguchi, T.; Satoh, T.; Sunaoshi, K.; Takeda, K.;. Clinical efficacy of sitafloxacin 100 mg twice daily for 7 days for patients with non-gonococcal urethritis. J. Infect. Chemother. 2013, 19, 941-945.